Global Short-acting Beta2-agonists (SABA) Market size, Industry Analysis, Share, Growth, Trends, Forecast 2017 - 2025

MarketResearchReports.Biz announces addition of new report" Short-acting Beta2-agonists (SABA) Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025"to its database.

​The objective of this report is to define, describe, and forecast the market on the basis of type, application, medical condition, and region. It provides detailed information regarding the major factors influencing the growth of the market. This report also tracks and analyzes competitive developments of the key players in terms of market developments, product portfolios, and financials.

Get Sample copy of this Report @​ https://www.marketresearchreports.biz/sample/sample/1375808

Short-acting beta2-agonists (SABA) are a type of bronchodilators. These are the most common immediate-relief drugs for treating asthma attacks and to manage both acute and stable exacerbations of chronic obstructive pulmonary disease (COPD). Salbutamol is the most commonly prescribed short-acting beta2-agonists (SABA) and is available under different brand names such as Salamol, Ventolin, and Proventil. The usage of short-acting beta-2-agonists SABAs on a regular basis for at least seven days in stable COPD is associated with the decrease in breathlessness and improvement in post bronchodilator lung function within 5 minutes. The inhaled form of the drug is available in metered-dose inhalers and as a liquid for compressor-driven nebulizers. Short-acting beta2-agonists (SABA) are utilized to treat symptoms in intermittent asthma, prevent asthma symptoms before exercise, and provide quick relief of symptoms during asthma attacks. A combination of ipratropium and short-acting beta2-agonists (SABA) in severe, acute asthma episodes results in improved lung function and fewer hospital visits.
Short-acting beta2 agonist (SABA) is known as a quick-acting and reliving medication from sudden asthma attacks, as it helps to rapidly open the airways. This is driving the global short acting beta2-agonists (SABA) market. Emergence of biologics to treat severe asthma and novel combination therapies are likely to drive the market. New technological advancements and product innovations lead to increased demand for the Short-acting beta2 agonist (SABA) drugs. However, the expiry of patents and exclusivity of branded drugs are restraining the market. Ability of the drug to keep asthma under control and increasing population suffering from asthma and chronic diseases such as chronic obstructive pulmonary disease are attributed to boost the global short acting beta2-agonists market. According to the World Health organization (WHO), in 2015, 383,000 people died due to asthma. Many asthma-related deaths occur in low- and lower-middle income countries. WHO also stated that approximately 235 million people are presently suffering from asthma, and it is a common disease among children.

View Report @​ https://www.marketresearchreports.biz/reports/1375808/short-acting-beta-agonists-saba-market-research-reports

WHO estimated that, in 2015, COPD caused 3 million deaths across the world, which accounts to approximately 5% of all deaths. The primary cause of COPD is exposure to tobacco smoke, either passive or active. Expansion of the market is attributed to the popularity and preference for short acting beta2-agonists. However, patent and exclusivity expiry of major selling drugs such as Serevent, restrains the global market. The global short-acting beta2 agonists (SABA) market can be segmented based on dosage form, application type, distribution channel, and region. Based on dosage form, the market can be segregated into solution, injectable, tablet, syrup, and elixir. In terms of the application type, the market can be segmented into Chronic Obstructive Pulmonary Disease (COPD) and asthma. Based on distribution channel, the market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies.

In terms of region, the market can be segmented into Asia Pacific, Latin America, Europe, North America, and Middle East & Africa. North America held a prominent share of the market in 2016 due to technological advancements in R&D of short acting beta2-agonists drugs. Europe followed North America in terms of market share in 2016 due to the increased prevalence of asthma. According to Asthma UK, 5.4 million people in the U.K. are currently diagnosed with asthma, approximately 1.1 million children, which accounts to 1 in 11, and 4.3 million adults, which accounts 1 in 12. The market in Asia Pacific, Latin America, and Middle East & Africa is estimated to expand during the forecast period due to the increasing population and air pollution.

Key players operating in the global short acting beta2-agonists (SABA) market include Mylan N.V., Teva Pharmaceutical Industries Ltd., Bayer AG, Actelion Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, and GlaxoSmithKline plc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request for Enquiry @ ​https://www.marketresearchreports.biz/sample/enquiry/1375808

The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Check Discount @ ​https://www.marketresearchreports.biz/sample/checkdiscount/1375808

Highlights of the report:
A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market

About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.